• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过工程化大肠杆菌实现牛磺熊去氧胆酸的快速定向生物转化。

Rapidly directional biotransformation of tauroursodeoxycholic acid through engineered Escherichia coli.

作者信息

Shi Jie, Wang Jie, Yu Lu, Yang Li, Zhao Shujuan, Wang Zhengtao

机构信息

The SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Complex Prescription, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Department of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

出版信息

J Ind Microbiol Biotechnol. 2017 Jul;44(7):1073-1082. doi: 10.1007/s10295-017-1935-y. Epub 2017 Mar 22.

DOI:10.1007/s10295-017-1935-y
PMID:28332050
Abstract

Bear bile powder is a precious medicinal material. It is characterized by high content of tauroursodeoxycholic acid (TUDCA) at a ratio of 1.0-1.5 to taurochenodeoxycholic acid (TCDCA). Here, we reported the biotransformation of tauroursodeoxycholic acid (TUDCA) through Escherichia coli engineered with a two-step mimic biosynthetic pathway of TUDCA from taurochenodeoxycholic acid (TCDCA). Two 7α-hydroxysteroid dehydrogenase (7α-HSDH) and two 7β-hydroxysteroid dehydrogenase (7β-HSDH) genes (named as α, α, β, and β) were selected and synthesized to create four pathway variants using ePathBrick. All could convert TCDCA to TUDCA and the one harboring α and β (pαβ) showed the strongest capability. Utilizing the oxidative and reductive properties of 7α- and 7β-HSDH, an ideal balance between TUDCA and TCDCA was established by optimizing the fermentation conditions. By applying the optimal condition, E. coli containing pαβ (BL-pαβ) produced up to 1.61 ± 0.13 g/L of TUDCA from 3.23 g/L of TCDCA at a ratio of 1.3 to TCDCA. This study provides a potential approach for bear bile substitute production from cheap and readily available chicken bile.

摘要

熊胆粉是一种珍贵的药材。其特点是牛磺熊去氧胆酸(TUDCA)含量高,与牛磺鹅去氧胆酸(TCDCA)的比例为1.0 - 1.5。在此,我们报道了通过工程改造的大肠杆菌将牛磺鹅去氧胆酸(TCDCA)生物转化为牛磺熊去氧胆酸(TUDCA),该大肠杆菌构建了一条从牛磺鹅去氧胆酸(TCDCA)两步模拟生物合成牛磺熊去氧胆酸(TUDCA)的途径。选择并合成了两个7α-羟基类固醇脱氢酶(7α-HSDH)和两个7β-羟基类固醇脱氢酶(7β-HSDH)基因(命名为α、α、β和β),使用ePathBrick创建了四个途径变体。所有变体都能将TCDCA转化为TUDCA,其中含有α和β的变体(pαβ)表现出最强的能力。利用7α-HSDH和7β-HSDH的氧化和还原特性,通过优化发酵条件在TUDCA和TCDCA之间建立了理想的平衡。应用最佳条件时,含有pαβ的大肠杆菌(BL-pαβ)以1.3的比例从3.23 g/L的TCDCA中产生高达1.61±0.13 g/L的TUDCA。本研究为从廉价易得的鸡胆汁生产熊胆替代品提供了一种潜在方法。

相似文献

1
Rapidly directional biotransformation of tauroursodeoxycholic acid through engineered Escherichia coli.通过工程化大肠杆菌实现牛磺熊去氧胆酸的快速定向生物转化。
J Ind Microbiol Biotechnol. 2017 Jul;44(7):1073-1082. doi: 10.1007/s10295-017-1935-y. Epub 2017 Mar 22.
2
Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory.通过工程大肠杆菌细胞工厂的发酵优化大规模生产牛磺熊去氧胆酸产品。
Microb Cell Fact. 2019 Feb 8;18(1):34. doi: 10.1186/s12934-019-1076-2.
3
A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae.利用工程化酿酒酵母生产熊胆潜在替代资源的绿色策略。
Bioresour Bioprocess. 2022 Mar 27;9(1):32. doi: 10.1186/s40643-022-00517-3.
4
Discovery of tauroursodeoxycholic acid biotransformation enzymes from the gut microbiome of black bears using metagenomics.利用宏基因组学从黑熊肠道微生物组中发现牛磺熊脱氧胆酸生物转化酶。
Sci Rep. 2017 Apr 24;7:45495. doi: 10.1038/srep45495.
5
Structural and functional characterization of a novel acidophilic 7α-hydroxysteroid dehydrogenase.新型嗜酸 7α-羟甾脱氢酶的结构与功能特征研究。
Protein Sci. 2019 May;28(5):910-919. doi: 10.1002/pro.3599. Epub 2019 Mar 22.
6
In search of sustainable chemical processes: cloning, recombinant expression, and functional characterization of the 7α- and 7β-hydroxysteroid dehydrogenases from Clostridium absonum.探索可持续的化学工艺:梭菌属亚种的 7α-和 7β-羟甾脱氢酶的克隆、重组表达和功能特征。
Appl Microbiol Biotechnol. 2012 Sep;95(5):1221-33. doi: 10.1007/s00253-011-3798-x. Epub 2011 Dec 25.
7
A novel 7α-hydroxysteroid dehydrogenase: Magnesium ion significantly enhances its activity and thermostability.一种新型 7α-羟甾脱氢酶:镁离子显著增强其活性和热稳定性。
Int J Biol Macromol. 2021 Apr 30;177:111-118. doi: 10.1016/j.ijbiomac.2021.02.082. Epub 2021 Feb 13.
8
Co-immobilised 7α- and 7β-HSDH as recyclable biocatalyst: high-performance production of TUDCA from waste chicken bile.共固定化7α-和7β-羟基类固醇脱氢酶作为可循环利用的生物催化剂:从废弃鸡胆汁中高效生产牛磺熊去氧胆酸
RSC Adv. 2018 Oct 4;8(60):34192-34201. doi: 10.1039/c8ra06798h.
9
Large-scale production of ursodeoxycholic acid from chenodeoxycholic acid by engineering 7α- and 7β-hydroxysteroid dehydrogenase.通过工程化 7α-和 7β-羟甾脱氢酶从鹅去氧胆酸大规模生产熊去氧胆酸。
Bioprocess Biosyst Eng. 2019 Sep;42(9):1537-1545. doi: 10.1007/s00449-019-02151-4. Epub 2019 Jun 1.
10
Xanthomonas maltophilia CBS 897.97 as a source of new 7beta- and 7alpha-hydroxysteroid dehydrogenases and cholylglycine hydrolase: improved biotransformations of bile acids.嗜麦芽窄食单胞菌CBS 897.97作为新型7β-和7α-羟基类固醇脱氢酶及胆酰甘氨酸水解酶的来源:胆汁酸生物转化的改进
Steroids. 2006 Mar;71(3):189-98. doi: 10.1016/j.steroids.2005.10.002. Epub 2005 Nov 22.

引用本文的文献

1
Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered with a multienzyme cascade.使用具有多酶级联反应的工程菌进行熊去氧胆酸的经济高效全细胞生物合成。
Front Microbiol. 2025 Jan 22;16:1538237. doi: 10.3389/fmicb.2025.1538237. eCollection 2025.
2
Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute.从鸡胆汁中合成牛磺熊去氧胆酸:用于生产人工熊胆替代品的固定化双酶系统
Microb Cell Fact. 2024 Dec 2;23(1):326. doi: 10.1186/s12934-024-02592-x.
3
A green strategy to produce potential substitute resource for bear bile using engineered Saccharomyces cerevisiae.

本文引用的文献

1
Improving Metabolic Pathway Efficiency by Statistical Model-Based Multivariate Regulatory Metabolic Engineering.基于统计模型的多变量调控代谢工程提高代谢途径效率
ACS Synth Biol. 2017 Jan 20;6(1):148-158. doi: 10.1021/acssynbio.6b00187. Epub 2016 Aug 15.
2
Optimizing Metabolic Pathways for the Improved Production of Natural Products.优化代谢途径以提高天然产物的产量。
Methods Enzymol. 2016;575:179-93. doi: 10.1016/bs.mie.2016.02.010. Epub 2016 Mar 10.
3
Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective.
利用工程化酿酒酵母生产熊胆潜在替代资源的绿色策略。
Bioresour Bioprocess. 2022 Mar 27;9(1):32. doi: 10.1186/s40643-022-00517-3.
4
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia.牛磺鹅去氧胆酸对高脂血症小鼠干预作用的代谢组学和脂质组学研究
Front Pharmacol. 2023 Nov 15;14:1255931. doi: 10.3389/fphar.2023.1255931. eCollection 2023.
5
Biological synthesis of ursodeoxycholic acid.熊去氧胆酸的生物合成
Front Microbiol. 2023 Feb 24;14:1140662. doi: 10.3389/fmicb.2023.1140662. eCollection 2023.
6
Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory.通过工程大肠杆菌细胞工厂的发酵优化大规模生产牛磺熊去氧胆酸产品。
Microb Cell Fact. 2019 Feb 8;18(1):34. doi: 10.1186/s12934-019-1076-2.
7
NAD -Dependent Enzymatic Route for the Epimerization of Hydroxysteroids.NAD -依赖性羟甾体差向异构酶促途径。
ChemSusChem. 2019 Jul 5;12(13):3192-3203. doi: 10.1002/cssc.201801862. Epub 2018 Nov 5.
用于治疗肝脏疾病的熊胆替代品:研究进展与未来展望
Evid Based Complement Alternat Med. 2016;2016:4305074. doi: 10.1155/2016/4305074. Epub 2016 Mar 21.
4
Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering.通过组合代谢工程提高大肠杆菌中儿茶素的产量。
Metab Eng. 2015 Mar;28:43-53. doi: 10.1016/j.ymben.2014.12.002. Epub 2014 Dec 17.
5
Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon.人结肠中瘤胃球菌 N53 的 7β-羟甾醇脱氢酶对熊去氧胆酸形成的贡献。
J Lipid Res. 2013 Nov;54(11):3062-9. doi: 10.1194/jlr.M039834. Epub 2013 Jun 1.
6
ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli.电子通路砖:用于构建大肠杆菌代谢途径的合成生物学平台。
ACS Synth Biol. 2012 Jul 20;1(7):256-66. doi: 10.1021/sb300016b. Epub 2012 May 4.
7
Modular optimization of multi-gene pathways for fatty acids production in E. coli.大肠杆菌中脂肪酸生产的多基因途径的模块化优化。
Nat Commun. 2013;4:1409. doi: 10.1038/ncomms2425.
8
One-step synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid using a multienzymatic system.一步法用多酶体系从脱氢胆酸合成 12-酮基去氧胆酸。
Appl Microbiol Biotechnol. 2013 Jan;97(2):633-9. doi: 10.1007/s00253-012-4340-5. Epub 2012 Aug 17.
9
Multi-enzymatic one-pot reduction of dehydrocholic acid to 12-keto-ursodeoxycholic acid with whole-cell biocatalysts.用全细胞生物催化剂将脱氢胆酸一锅法多酶还原为 12-酮熊去氧胆酸。
Biotechnol Bioeng. 2013 Jan;110(1):68-77. doi: 10.1002/bit.24606. Epub 2012 Sep 18.
10
Novel whole-cell biocatalysts with recombinant hydroxysteroid dehydrogenases for the asymmetric reduction of dehydrocholic acid.新型全细胞生物催化剂,具有重组羟甾脱氢酶,用于脱氢胆酸的不对称还原。
Appl Microbiol Biotechnol. 2012 Sep;95(6):1457-68. doi: 10.1007/s00253-012-4072-6. Epub 2012 May 15.